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Background: The Cancer Networks Supporting Primary Care programme was a National Health Service (NHS) initiative in England
between 2011 and 2013 that aimed to better understand and improve referral practices for suspected cancer.
Methods: A mixed methods evaluation using semi-structured interviews with purposefully sampled key stakeholders and
an analysis of Cancer Waiting Times and Hospital Episode Statistics data for all 8179 practices in England were undertaken.
We compared periods before (2009/10) and at the end (2012/13) of the initiative for practices taking up any one of four specified
quality improvement initiatives expected to change referral practice in the short to medium term and those that did not.
Results: Overall, 38% of general practices were involved in at least one of four quality improvement activities (clinical audit,
significant event analysis, use of risk assessment tools and development of practice plans). Against an overall 29% increase in
urgent cancer referrals between 2009/10 and 2012/13, these practices had a significantly higher increase in referral rate, with
reduced between-practice variation. There were no significant differences between the two groups in conversion, detection or
emergency presentation rates. Key features of successful implementation at practice and network level reported by participants
included leadership, organisational culture and physician involvement. Concurrent health service reforms created organisational
uncertainty and limited the programme’s effectiveness.
Conclusions: Specific primary care initiatives promoted by cancer networks had an additional and positive impact on urgent
referrals for suspected cancer. Successful engagement with the programmes depended on effective and well-supported
leadership by cancer networks and their general practitioner (GP) leads.
The English National Awareness and Early Diagnosis Initiative
(NAEDI; Richards, 2009) was launched in 2008, in response to the
Cancer Reform Strategy (Department of Health, 2007), in order to
understand and address the reasons for late diagnosis of cancer in
England. One of its four work streams aimed to overcome clinical and
system barriers to prompt onward referral within and between
primary and secondary care, with a focus on general practitioner (GP)
awareness of symptoms and interaction with patients, the interface
between primary and secondary care, including any disincentives to
referral, and the commissioning and ‘gatekeeper’ function of GPs
(Cancer Research UK, 2010). The National Awareness and Early
Diagnosis Initiative is a public sector/third sector partnership, led by
National Health Service (NHS) England, Public Health England,
Cancer Research UK and the Department of Health. Until April 2013,
The National Cancer Action Team (NCAT) played a key role, on
behalf of NHS England, in its implementation.
Early NAEDI initiatives in primary care included a National
Audit of Cancer Diagnosis (Rubin et al, 2011) and the
development of a significant event analysis template applicable
to cancer diagnosis (Mitchell et al, 2012). The role of a GP lead
within a cancer network was developed and systematically
implemented throughout England, initially to support the
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introduction of General Practice Profiles for Cancer in 2010
(National Cancer Intelligence Network, 2014). Following the
publication of Improving Outcomes: a Strategy for Cancer
(Department of Health, 2011), a programme of centrally
coordinated, locally delivered improvement initiatives com-
menced, titled Cancer Networks Supporting Primary Care.
As this programme progressed, its focus narrowed down to those
initiatives that key stakeholders felt were having the greatest
impact, notably, but not exclusively, review of practice profiles for
cancer and development of practice action plans, use of risk
assessment tools, clinical audit and significant event analysis
(Box 1). GP leads were instrumental in encouraging practices to
take up one or more of these activities.
During the same period, the English NHS was the subject of
major organisational reform, much of which became operational in
April 2013 (Department of Health, 2010). As a result, cancer
networks were subsumed into a smaller number of strategic clinical
networks, with a remit for quality improvement that embraced
multiple clinical areas in addition to cancer.
The evaluation of large-scale quality improvement initiatives,
particularly those in which the implementation of a national policy
direction is locally determined, presents organisational and
methodological challenges. Circumstances, capacity and timescale
may preclude an optimal design, whereas choice of methods and
outcome measures can influence the utility of findings (Salisbury
et al, 2010). There are few reported evaluations of large-scale
transformational change in the peer-reviewed literature. A mixed
method approach has been adopted for some comparable policy-
driven initiatives, notably the evaluation of the Department of
Health Integrated Care Pilots (Ling et al, 2010), whereas realist
evaluation has been increasingly used to better understand the
complex relationships between context, mechanisms and outcomes
– for example, in the London Modernisation Initiative (Greenhalgh
et al, 2009). One of the most significant quality improvement
initiatives in the UK, ‘Pay for Performance’, has been the subject of
a programme of research utilising a wide range of methodologies in
multiple individual studies (Gillam et al, 2012). For this evaluation,
we aimed to understand the context in which the programme was
implemented, the mechanisms used to effect its introduction and
the extent to which its objectives were achieved.
MATERIALS AND METHODS
A logic model for the programme, constructed with the help of key
stakeholders, informed our evaluation (Supplementary Online
Material and Supplementary Online Figure 1). We adopted a
mixed methods approach to evaluation. We undertook serial one-
to-one semi-structured interviews with a purposive sample of key
individuals, identified by NCAT and Cancer Network Directors,
based on their knowledge of a person’s involvement in the
development and delivery of the programme. An interview guide
was developed from the Logic Model and used on each occasion.
Interviews were recorded and were professionally transcribed.
Transcripts were read and re-read independently by two members
of the research team and a coding frame constructed, which was
then applied to the data to identify emerging themes. We also
undertook documentary analysis of meeting notes, activity logs,
practice plans and other materials used by the networks. Analysis
drew on principles of realist evaluation (Pawson and Tilley, 1997)
to develop a contextualised account of the way in which change
emerged, initially considering the individual components of the
logic model (Ablett-Spence et al, 2012, 2013). In this paper, we
report the cross-cutting themes that emerged from that analysis.
We also compared our findings against the contextual barriers and
facilitators to quality improvement identified in a recent systematic
review (Kaplan et al, 2010).
Because impact on referral practice was identified as a key
outcome for the programme, we compared referral activity in the 12
months to March 2010, that is, before the start of the programme,
with the same period to March 2013. We hypothesised a priori, in
consultation with NCAT, that four specific activities (clinical audit,
significant event analysis, use of risk assessment tools and practice
plans for cancer) would change clinical and referral practice in the
short to medium term, and compared those practices that chose to
engage at any point in one or more of these against those that did
not engage in any of the four.
From Cancer Waiting Times (CWT) data, we obtained the
number of urgent GP referrals for all suspected cancers from April
2009 to March 2013, based on ‘date first seen’, and the number of
cancers receiving a first treatment during the same period, based
on ‘treatment start date’. These data were used to calculate referral
rate, conversion rate (percentage of urgent GP referrals resulting in
a cancer diagnosis) and detection rate (percentage of CWT
recorded cancers resulting from an urgent GP referral).
A validated algorithm (National Cancer Intelligence Network,
2013) was applied to Hospital Episode Statistics (HES) patient care
data to identify new cancer cases and their mode of presentation
and then to calculate the percentage of HES-identified cancers first
presenting as an emergency. Emergency presentation was defined
as emergency in-patient admission from an A&E department or an
outpatient clinic or a GP or Bed Bureau referral, or referral to
outpatients following A&E attendance or emergency admission
(National Cancer Intelligence Network, 2013).
We examined data for all practices present in the 2009/10
Quality and Outcomes Framework (QOF) data set. On the basis of
2009/10 and 2011/12 QOF list sizes and Attribution Data Set
populations from 2009 and 2012, practices with significant changes
in practice list size (410% change in practice population within
the considered period) and very small practices (o1000 popula-
tion) were excluded from the analyses.
Box 1. NAEDI supporting primary care practice activities
Clinical audit
An audit of new cancer diagnoses (excluding screen-detected and non-
melanotic skin cancers), usually for the previous 12 months. Practices use a
standard audit template developed by and freely available from the Royal
College of General Practitioners (RCGP).
Significant event analysis
An approach to quality improvement that is well established in general
practices. It involves a structured review by the practice team of all that
happened in relation to an event of interest, which may be adverse, exemplary
or simply important (in this case the diagnosis of cancer). It addresses the
questions: What happened? Why did it happen? What can be learnt? What
should be changed?
Practice cancer plans
A practice team activity, typically undertaken following review of the
practice’s cancer profile (a report of performance against 25 metrics for
cancer screening and diagnosis provided annually by the National Cancer
Intelligence Network). Guidance and a template for practice plans are freely
available from the RCGP. The plan records key data related to current activity
and helps to establish targets for the future. It then details the key tasks to be
undertaken in order to improve cancer-related activities.
Risk assessment tools
These provide GPs with estimates of the risk of a specified cancer for
individual symptoms, combinations of symptoms and for repeat consultation
with the same symptom. Initially available as mouse mats and desk easels,
they were widely distributed by NCAT. They were later provided to a limited
number of practices on an electronic platform that interfaced with the practice
clinical system.
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Statistical methods. Referral rates were directly age-standardised
(Fay and Feuer, 1997). For the percentage change in referral rate,
95% confidence intervals were derived by transformation of
confidence intervals for the rate ratio. For individual GP practices,
indirectly age- and sex-standardised referral ratios (SRR) were
calculated, based on the number of referrals expected given the
practice population structure and the age- and sex-specific referral
rates for England, with an SRR of 100 representing the expected
referral rate.
The statistical significance of changes, from the before to after
period, was determined by means of hypothesis tests, with a
considered significance level of 95%. For age-standardised referral
rates, the z-tests considered the null hypothesis that the ratio of the
before and after period referral rates was equal. For GP practice
level rates, Brown and Forsythe (1974) tests considered the null
hypothesis that there was the same variance in the rates in the
before period as in the after period.
RESULTS
Referral activity. We obtained data on cumulative activity in
relation to the programme from all 28 cancer networks in England
and for 8179 practices. For eight networks (2374 practices), we
received activity data up to March 2012 only. Of practices in the
2009/10 QOF data, 1819 were removed from the analysis; 537 of
these practices had taken up a specified activity. A further 27
practices with a record of at least one specified activity were
excluded because they were not in the 2009/10 QOF data.
By March 2013, 2495 (38%) of the practices included in the
analysis had taken up one or more of the specified activities.
Practices taking up any of these activities had larger list sizes than
those that did not and were less likely to be serving deprived areas
(Table 1).
Against an overall 29% increase in 2-week referral rates between
2010 and 2013, there was a significantly greater increase for
practices engaging in any of the four specified activities, but no
significant differences in conversion, detection or emergency
presentation rates (Table 2). There were no consistent and
significantly greater changes for those practices that engaged in
more than one activity. In the period under study, the overall
conversion, detection and emergency presentation rates all
changed significantly. The conversion rate fell by 1.3 percentage
points to 10.2% and the detection rate rose 3.9 percentage points to
47.8%. Emergency presentations fell from 23.4% to 21.1%. There
was a significant reduction in the variability of referral ratios and
conversion, detection and emergency presentation rates, with a
notably larger reduction in the interquartile range of referral ratios
for ‘activity’ practices compared with those not taking up any
specified activity (Table 3). In subanalyses, those practices taking
up risk assessment tools showed a significantly greater increase in
referral rate for suspected colorectal cancer but not for suspected
lung cancer. Conversion and detection rates were not significantly
different (Supplementary Online Material; and Supplementary
Online Tables 1 and 2).
Qualitative findings. We conducted interviews with 92 partici-
pants, 38 of whom were interviewed twice and 7 were interviewed
three times. They included GPs, GP cancer leads, public health
specialists and cancer network staff. Thirty-two participants
declined a second interview because they felt they had nothing
new to add. Fifteen participants were interviewed for a first time
because they had taken the place of an earlier interviewee who had
left that post.
Organisational context and culture. A key contextual factor was
the structure of cancer networks and, latterly, the ease or otherwise
with which they managed the transition to being part of
geographically larger and more clinically diverse strategic clinical
networks. A major challenge was to keep engaged those individuals
whose role or job security was threatened by this reorganisation:
‘It’s been really difficult to implement things, people aren’t
motivated when their jobs aren’t secure and it’s hard to speak to
key people, as staff are moving into different posts or leaving all
the time. There is just no continuity.’ – Network Director
At the general practice level, interviewees reported a diversity of
practice cultures that demanded flexibility in approaches to
engagement. Networks that tried a ‘one size fits all’ approach
reported less success in implementing quality improvement
initiatives.
Leadership. The programme had consistently strong leadership
from the NCAT, with excellent communication and a supportive
approach allied to regular monitoring of progress. In cancer
networks, effective leadership was associated with organisational
stability and consistent messaging. When this was the case,
participants reported clinicians feeling better supported to sustain
their improvement activities, better engagement with secondary-
care clinicians and improvement initiatives focussed on the
primary/secondary care interface.
Networks with strong and proactive GP leads reported better
engagement with practices, and had greater success in implement-
ing and sustaining initiatives, attributing this to their leads being
able to articulate professional and personal relevance to their peers.
Support. Network GP leads reported that administrative and
project management support was key in enabling them to function
efficiently. In the early stages of the programme, this was patchy
and those who lacked it reported being less effective in engaging
with their GP colleagues. Moreover, the type of support varied
greatly, from a small amount of secretarial support to a project
manager.
Some networks developed a Primary Care Facilitator role to
complement their GP lead. Although facilitators and GP leads
often reported that the role needed to be validated by the GP lead
to be seen as credible by practices, they were highly valued by GP
and network programme leads for the additional capacity and skills
they brought:
‘So their role was about engaging the whole practice team, about
going in, about following up and maybe exploring in a bit more
detail some of the issues that the GP (lead) had discussed.
Because say you only had an hour, it doesn’t always get through,
people need to come back and explore it, and particularly things
like the risk assessment tool might need two or three goes for
people to understand.’ – Network Programme Lead
Communication. Communicating consistent messages in relation
to the programme, across a cancer network made up of multiple
organisations, each with their own systems, processes and cultures,
made implementation difficult. Newsletters were common, but
other methods including podcasts and videos were also tried.
Established methods of communication were usually more effective
than creating something new. There were also concerns about
information overload in general practice:
‘I mentioned it (information pack) at a practice visit and
they just looked blank. It turns out they had never seen it
and it was in the practice library or something, but when
they found it and looked at it they thought it was really useful.’
– GP lead
Education and training. All networks invested significant time
and effort into providing training in cancer awareness and
diagnosis to GPs and other primary care professionals. In general,
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attendance was better when such training was incorporated in
formal protected learning sessions than when provided on an ad
hoc basis. Although a range of teaching methods were utilised, a
range of approaches kept training interesting and different:
‘So for example, I’ve created a short video about how to use digital
cameras (to monitor pigmented lesions); how to upload it on to
clinical systems etc. So for us, video is becoming a more integral
part of how we offer resources. So as well as paper and online we
also offer video and nowadays, the interactive PDF.’ – GP lead
Although education in itself was perceived as being important,
the discussion that it generated was considered even more valuable
by GP and network leads, often signalling a commitment to
actively engage with the programme. Practices that were the
hardest to engage with the programme were often those whose
practitioners did not attend education and training sessions.
DISCUSSION
A national initiative to improve early detection of cancer was
associated with considerable overall improvement in referral
practice. Four specific primary care initiatives promoted by cancer
networks had an additional and positive impact and reduced
between-practice variation. Success in involving practices with the
programme was associated with strong clinical and organisational
leadership, good clinical engagement with education and training,
and a supportive organisational culture. Concurrent health service
reforms had a destabilising effect, notably when small leadership
teams lost key personnel.
Strengths and limitations. It is remarkable that we were able to
obtain activity data for all practices in England, while the CWT
database and HES data are well understood and reliable sources.
We used a wide range of informants and serial interviews in order
to develop our understanding of the implementation of the
programme as it progressed. We were strongly supported by the
NCAT in obtaining access to key informants. GP leads in cancer
networks were instrumental in our obtaining highly complete data
on practice participation in the specific initiatives associated with
the programme.
We used realist evaluation as our methodological approach to
analysis for the qualitative data. This theory-driven approach helps
to illuminate if and why certain elements of an initiative resulted in
particular outcomes and aids the understanding of ‘what worked
for whom and in what circumstances’. It is being increasingly
recognised as a valuable means of understanding how particular
preconditions make intended outcomes more or less likely
(Pawson and Tilley, 1997).
This evaluation was heavily dependent on individuals in
networks, both for data collection and for participation in
interviews. Because of the NHS reforms, a number of them lost
or changed their jobs during the period of the study. This
contributed to us only receiving interim practice activity data from
eight cancer networks.
The views of interview participants may not be representative of
the range of views held among those involved in the programme’s
implementation. Although we were able to sample from lists of key
stakeholders provided to us by NCAT and Cancer Network
directors, both had an interest in the programme succeeding and
we cannot exclude attribution or social desirability bias. However,
we did encounter negative as well as positive perspectives in the
course of our interviews, and a number of our participants were
aware that their future lay elsewhere. Indeed, our decision to
undertake serial interviews was affected by some loss of continuity
of key informants and related loss of corporate memory.
Our analysis of routinely collected activity data has some
limitations. The detection rate is based only on cases recorded in
the CWT data, rather than on a complete record of cancer
registrations, and the emergency presentation rate is based only on
cases identified from the HES data. The periods chosen for study
are not exclusively before and at the end of all initiatives; a number
of clinical audits were started and some completed before March
Table 2. Reported use of any specified NAEDI activity; impact on referral metrics (all cancers)
Number of practices with a change in the
same direction
Year to
March 2010a
(CI) (pre)
Year to
March 2013a
(CI) (post) Change (CI) Total Significant
2WW referral rateb (per 100000)
All practices 1437.9 (1434.6, 1441.2) 1856.4 (1852.7, 1860.0) 418.5 (29.1%) (28.7, 29.5) 5497 (84.8%) 3473 (53.5%)
Any specified activity 1441.2 (1436.1, 1446.3) 1872.1 (1866.4, 1877.9) 430.9 (29.9%) (29.3, 30.5) 2143 (85.9%) 1431 (57.4%)
No specified activity 1435.5 (1431.2, 1439.8) 1845.1 (1840.4, 1850.0) 409.7 (28.5%) (28.0, 29.0) 3354 (84.0%) 2042 (51.2%)
Conversion rate (%)
All practices 11.4 (11.4, 11.5) 10.2 (10.1, 10.2) 1.3 (1.4,  1.2) 3867 (59.6%) 550 (8.5%)
Any specified activity 11.5 (11.4, 11.6) 10.1 (10.0, 10.2) 1.4 (1.5,  1.2) 1512 (60.6%) 235 (9.4%)
No specified activity 11.4 (11.3, 11.5) 10.2 (10.1, 10.3) 1.2 (1.3,  1.1) 2355 (59.0%) 315 (7.9%)
Detection rate (%)
All practices 43.9 (43.6, 44.1) 47.8 (47.5, 48.0) 3.9 (3.6, 4.2) 3882 (59.9%) 412 (6.4%)
Any specified activity 43.7 (43.4, 44.1) 47.9 (47.6, 48.3) 4.2 (3.8, 4.7) 1556 (62.4%) 167 (6.7%)
No specified activity 43.9 (43.7, 44.2) 47.6 (47.3, 47.9) 3.7 (3.3, 4.1) 2326 (58.3%) 245 (6.1%)
Emergency presentation rate (%)
All practices 23.4 (23.2, 23.6) 21.1 (20.9, 21.2) 2.3 (2.6,  2.1) 3655 (56.4%) 255 (3.9%)
Any specified activity 23.2 (22.9, 23.5) 21.0 (20.7, 21.2) 2.2 (2.6,  1.8) 1417 (56.8%) 98 (3.9%)
No specified activity 23.5 (23.3, 23.7) 21.1 (20.9, 21.4) 2.4 (2.7,  2.0) 2238 (56.1%) 157 (3.9%)
Abbreviations: CI¼ confidence interval; GP¼general practitioner; NAEDI¼National Awareness and Early Diagnosis Initiative; 2WW¼ 2-week wait.
aYears to December 2009 and December 2012 for emergency presentation rate
bFor practice groups, referral rates are directly age-standardised using the 1976 European standard population weights, shown with 95% CIs based on the Gamma distribution (Fay and Feuer,
1997). For individual GP practices, results here are based on the crude referral rate.
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2010, but this is the earliest year for which reliable and complete
CWT data are available. For reasons of data availability, HES data
were considered for the 12-month periods between December 2009
and December 2012.
We did not obtain data on the timing of uptake of initiatives
by individual practices, nor were we able to measure the
quality or completeness of their participation. As such, the extent
to which subsequent referral practice could be influenced by
participation (the ‘dose effect’) will have varied between practices.
Comparison with other research. Our findings are broadly
consistent with those of a recent systematic review of factors
Table 3. Change in variability of practice level rates reported by the interquartile range and a test for change in variance, by
intervention group
Practice group Interquartile range
Year to
March 2010
Year to
March 2013 Change
P-value for
change
in variance
Standardised referral ratio
Any specified activity 49.6 39.4 10.1 o0.001
No specified activity 52.9 46.6 6.4 o0.001
Practice plans, clinical audit and significant event analysis 47.4 35.0 12.4 0.022
Practice plans and clinical audit 63.7 43.7 20.0 0.003
Practice plans and significant event analysis 49.9 45.9 3.9 0.243
Clinical audit and significant event analysis 47.9 36.9 11.1 0.020
Practice plans 49.5 44.9 4.7 0.274
Clinical audit 47.6 39.3 8.3 o0.001
Significant event analysis 52.4 37.9 14.5 o0.001
No practice plans, clinical audits or significant event analysis 52.2 45.3 6.9 o0.001
Risk assessment tools 49.2 42.0 7.2 o0.001
No risk assessment tools 52.3 44.7 7.7 o0.001
Conversion rate
Any specified activity 6.7 5.6 1.2 o0.001
No specified activity 7.0 5.8 1.2 o0.001
Practice plans, clinical audit and significant event analysis 6.5 5.8 0.8 0.079
Practice plans and clinical audit 7.4 5.7 1.7 0.165
Practice plans and significant event analysis 6.3 4.5 1.9 0.026
Clinical audit and significant event analysis 6.8 5.8 1.0 0.028
Practice plans 7.4 6.3 1.1 0.103
Clinical audit 6.5 5.0 1.5 0.004
Significant event analysis 7.1 4.5 2.6 o0.001
No practice plans, clinical audits or significant event analysis 6.9 5.7 1.2 o0.001
Risk assessment tools 6.9 5.7 1.2 o0.001
No risk assessment tools 6.9 5.6 1.2 o0.001
Detection rate
Any specified activity 18.2 15.6 2.6 0.002
No specified activity 18.5 16.6 1.9 o0.001
Practice plans, clinical audit and significant event analysis 17.8 16.4 1.3 0.656
Practice plans and clinical audit 15.9 16.3 0.4 0.262
Practice plans and significant event analysis 13.6 14.4 0.9 0.726
Clinical audit and significant event analysis 18.9 14.9 4.1 0.097
Practice plans 16.7 18.1 1.4 0.985
Clinical audit 16.7 14.4 2.2 0.894
Significant event analysis 18.4 15.8 2.6 0.006
No practice plans, clinical audits or significant event analysis 18.5 16.4 2.1 o0.001
Risk assessment tools 18.1 15.6 2.5 0.004
No risk assessment tools 18.5 16.5 2.0 o0.001
Interquartile range
Year to
December 2009
Year to
December 2012 Change
P-value for
change in
variance
Emergency presentation rate
Any specified activity 12.2 11.3 0.9 0.032
No specified activity 13.1 12.4 0.7 0.013
Practice plans, clinical audit and significant event analysis 11.7 10.5 1.2 0.154
Practice plans and clinical audit 10.8 10.9 0.1 0.776
Practice plans and significant event analysis 10.2 11.2 1.0 0.657
Clinical audit and significant event analysis 11.9 10.6 1.3 0.961
Practice plans 14.7 10.9 3.8 0.128
Clinical audit 12.8 12.7 0.1 0.770
Significant event analysis 10.9 9.8 1.1 0.106
No practice plans, clinical audits or significant event analysis 13.0 12.2 0.8 0.003
Risk assessment tools 12.0 11.4 0.6 0.086
No risk assessment tools 13.3 12.1 1.2 0.006
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influencing quality improvement success in health care (Table 4;
Kaplan et al, 2010). In particular, we found that leadership from
senior management and clinical engagement were important
facilitators, and that organisational culture, under challenge from
concurrent health service reforms, could be an important barrier.
However, we also identified poor communication as a key barrier,
whereas training and education, particularly for its ability to
stimulate the practice as a team to action, was a powerful
facilitator.
In the evaluation of a comparably large-scale initiative of
Integrated Care Pilots in England, failure to actively gain participa-
tion of key staff groups, such as GPs, made progress difficult (Ling
et al, 2012). In the United Kingdom, GPs are comparatively
autonomous, with no strong overarching management structure.
Implementing change presents unique challenges; who manages this
change and how it is introduced are key to it being accepted by
professionals who may feel their professional autonomy is under
threat. The key influencing role played by GP leads in this
programme can be interpreted as ‘soft coercion’ (Sheaff et al,
2003), a form of leadership seen in ‘soft bureaucracies’, organisations
characterised by a largely autonomous professional group, in this
case GPs, which is part of a structure that has a rigid framework and
provides governance (Courpasson, 2000).
There is limited literature reporting interventions in primary
care to modify referral for suspected cancer. A recent systematic
review of interventions to reduce primary care delay in cancer
referral identified four studies with relevant referral outcomes
(Mansell et al, 2011). Two had a demonstrable effect: the first
found that an educational intervention for suspected prostate
cancer reduced referrals, whereas an RCT of dermoscopy and a
three-point checklist for suspected skin cancer found that the
intervention increased referral sensitivity (conversion rate) and
accuracy. In a report of two consecutive cancer audits in Scotland,
the detection rate for all cancers in one Health Board area
increased from 46% to 58% following an intensive educational
intervention, although the quality of the data was poor and likely to
be subject to ascertainment bias (Baughan et al, 2009).
As referral rates increased between 2010 and 2013, so
conversion rates reduced from 11.4% to 10.2%. This inverse
relationship has been previously described (Meechan et al, 2012)
and reflects a predictable regression towards the risk of cancer
associated with National Institute for Health and Care Excellence
criteria for urgent referral, which is generally around 5%.
Implications for practice and future research. The differential
changes in referral practice found in this evaluation were small and
arguably not clinically significant when viewed in the context of
much larger overall changes during the same period. Influences to
which all primary care clinicians were exposed, such as the growing
public discourse about delays in cancer diagnosis and outputs from
the wider NAEDI, are likely to have had a greater effect. Referral
practice is only one means by which to assess quality of care, and
future evaluation should consider measures of consultation
frequency, use of diagnostic tests, time to referral and to diagnosis,
stage at diagnosis and patient experience.
We are unable to say whether the activities promoted through
this quality improvement programme have become part of the
culture and clinical practice for GPs. On the basis of the experience
of other large-scale initiatives in primary care (Audit Scotland,
2013), it is likely that sustained leadership and support with
resources will be needed, together with an evolving range of actions
that actively involve practices.
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(þ )¼ Facilitator
( )¼Barrier
Leadership from senior
management
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( ) Perceived professional
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structure and function in a range of
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moving into local authorities
( ) Changes in professional roles
( ) Public service bureaucracy
Data infrastructure and information
systems
(þ ) Effective data linkage or
alternative ways to exchange
information
( ) Systems that conflict between
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unable to share data, for example,
between CRUK and GPs
Previous involvement in quality
improvement
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between participating organisations
(þ ) New partnerships for some
initiatives – generates enthusiasm
Physician involvement (þ ) Clinical leadership
(þ ) GP engagement (areas with
good engagement were much more
successful)
Microsystem motivation to change (þ ) Some individual staff feel
personal benefit as a result of
changing (altruism or professional
gain)
( ) Some staff not motivated to
change due to job/role not being
secure
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NAEDI aims
(þ ) Common belief in the value of
NAEDI
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financial and employment
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